BrainScope, a commercial-stage medical neurotechnology company applying artificial intelligence and computational neuroscience to brain electrical activity (EEG), today announced the publication of a ...
Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope’s strategic focus on early, actionable dementia detection. BrainScope, a commercial ...
The MarketWatch News Department was not involved in the creation of this content. Non-invasive EEG biomarker identifies risk of future cognitive decline long before diagnosis, reinforcing BrainScope's ...